Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bargiela-Iparraguirre, J.
21  Ergebnisse:
Personensuche X
?
1

Regulatory effects of miR-19a on MAD2 expression and tumori..:

Bargiela-Iparraguirre, J. ; Herrero, J.M. ; Pajuelo-Lozano, N....
Genes & Diseases.  10 (2023)  4 - p. 1180-1182 , 2023
Link: https://doi.org/10.1016/..
 
?
2

CHK1 expression in Gastric Cancer is modulated by p53 and R..:

Bargiela-Iparraguirre, J. ; Prado-Marchal, L. ; Fernandez-Fuente, M....
Scientific Reports.  6 (2016)  1 - p. , 2016
Link: https://doi.org/10.1038/..
 
?
3

Mad2 and BubR1 modulates tumourigenesis and paclitaxel resp..:

Bargiela-Iparraguirre, J ; Prado-Marchal, L ; Pajuelo-Lozano, N...
Cell Cycle.  13 (2014)  22 - p. 3590-3601 , 2014
Link: https://doi.org/10.4161/..
 
?
4

Targeting Chk2 improves gastric cancer chemotherapy by impa..:

Gutiérrez-González, A. ; Belda-Iniesta, C. ; Bargiela-Iparraguirre, J....
Apoptosis.  18 (2012)  3 - p. 347-360 , 2012
Link: https://doi.org/10.1007/..
 
?
5

XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin..:

Pajuelo-Lozano, Natalia ; Bargiela-Iparraguirre, Jone ; Dominguez, Gemma...
Frontiers in Pharmacology.  9 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
6

Regulatory effects of miR-19a on MAD2 expression and tumori..:

J. Bargiela-Iparraguirre ; J.M. Herrero ; N. Pajuelo-Lozano...
http://www.sciencedirect.com/science/article/pii/S2352304223000776.  , 2023
Link: https://doi.org/10.1016/..
 
?
7

CHK1 expression in gastric cancer is modulated by p53 and R..:

Bargiela-Iparraguirre, J ; Prado-Marchal, L ; Fernandez-Fuente, M...
Scientific Reports.  , 2017
Link: http://hdl.handle.net/10..
 
?
8

CHK1 expression in Gastric Cancer is modulated by p53 and R..:

Bargiela-Iparraguirre, J ; Prado-Marchal, L ; Fernandez-Fuente, M...
https://researchonline.rvc.ac.uk/id/eprint/10211/1/10211.pdf.  , 2016
Link: https://researchonline.r..
 
?
9

XPA, XPC, and XPD modulate sensitivity in gastric cisplatin..:

Pajuelo-Lozano, Natalia ; Bargiela-Iparraguirre, Jone ; Domínguez, Gemma...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2018
Link: http://hdl.handle.net/10..
 
?
10

XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin..:

Pajuelo-Lozano, Natalia ; Bargiela-Iparraguirre, Jone ; Dominguez, Gemma...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199368/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
11

XPA, XPC, and XPD modulate sensitivity in gastric cisplatin..:

Pajuelo-Lozano, Natalia ; Bargiela-Iparraguirre, Jone ; Domínguez, Gemma...
Frontiers in Pharmacology.  , 2018
Link: http://hdl.handle.net/10..
 
?
12

Estudio de biomarcadores de pronóstico y respuesta a terapi..:

Bargiela-Iparraguirre, Jone
Publisher's version.  , 2017
Link: http://hdl.handle.net/10..
 
?
13

CHK1 expression in gastric cancer is modulated by p53 and R..:

Bargiela-Iparraguirre, Jone ; Prado-Marchal, L ; Gutiérrez-González, A...
Publisher's version.  , 2016
Link: http://hdl.handle.net/10..
 
?
14

Image_1_XPA, XPC, and XPD Modulate Sensitivity in Gastric C..:

Natalia Pajuelo-Lozano ; Jone Bargiela-Iparraguirre ; Gemma Dominguez...
doi:10.3389/fphar.2018.01197.s001.  , 2018
Link: https://doi.org/10.3389/..
 
?
15

Image_4_XPA, XPC, and XPD Modulate Sensitivity in Gastric C..:

Natalia Pajuelo-Lozano ; Jone Bargiela-Iparraguirre ; Gemma Dominguez...
doi:10.3389/fphar.2018.01197.s004.  , 2018
Link: https://doi.org/10.3389/..
 
1-15